Clinical Research Directory
Browse clinical research sites, groups, and studies.
TRE in Type 2 Diabetes (See Food Study 3)
Sponsor: University of Minnesota
Summary
Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.
Official title: TRE in Type 2 Diabetes Mellitus (See Food Study 3)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
115
Start Date
2022-05-27
Completion Date
2026-03-31
Last Updated
2026-03-18
Healthy Volunteers
Yes
Conditions
Interventions
Time restricted eating
Limiting daily eating time to an 8 hour window
Caloric reduction
Cut caloric intake by 15%
Locations (1)
University of Minnesota
Minneapolis, Minnesota, United States